FDA Approves New HPV Test that Detects and Identifies HPV Genotypes that put Women at High Risk for Cervical Cancer

The BD Onclarity HPV Assay can detect 14 high-risk HPV types and provide additional information to guide physician decision-making FRANKLIN LAKES, N.J., Feb. 13, 2018 -- (Healthcare Sales & Marketing Network) -- BD (Becton, Dickinson and Company) (NYS... Diagnostics, FDA BD , BD Onclarity, HPV assay, human papillomavirus

http://salesandmarketingnetwork.com/news_release_bs.html?ID=2043509

Source: HSMN NewsFeed - February 13, 2018 Category: Pharmaceuticals Source Type: news